BioCentury
ARTICLE | Clinical News

Compugen preclinical data

July 19, 2010 7:00 AM UTC

In a mouse model of RRMS, CGEN-15001 resulted in complete eradication of spontaneous relapses when administered after disease onset. When administered before disease onset, CGEN-15001 demonstrated a p...